Navigation Links
VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent
Date:8/19/2008

cence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers in vivo. All of the VisEn imaging agents are designed for use with VisEn's Quantitative Tomographic FMT imaging systems to enable quantitative data on biological targets in vivo. They are also compatible with a range of additional fluorescence imaging systems, including planar systems and intravital microscopes.

Additional product information can be obtained by calling Customer Support at VisEn Medical: 781-932-6875, ext. 315, via email at: info@visenmedical.com; or at http://www.visenmedical.com.

About VisEn Medical

VisEn Medical develops and commercializes the industry's highest performing fluorescence in vivo imaging technology platforms, from research through medicine. Founded in 2000 based on fluorescence in vivo imaging technologies developed by industry-leading researchers and clinicians at the Massachusetts General Hospital and Harvard Medical School, VisEn's FMT Fluorescence Tomography imaging systems and suite of molecular imaging agents are used to quantify biological mechanisms of disease and therapeutic response in vivo. These systems are widely used by leading research institutions and pharmaceutical companies in disease areas including oncology, inflammation, cardiovascular, skeletal and pulmonary diseases. The Company also works with pharmaceutical and clinical partners to design and develop ranges of tailored molecular imaging agents and applications that are targeted to their specific pre-clinical and clinical research areas. For further information please visit http://www.visenmedical.com.


'/>"/>
SOURCE VisEn Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
2. VisEn Medical Raises $7 Million in Series B Financing
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... County, N.Y. (PRWEB) June 17, 2013 ... the world's best-engineered batteries, has announced the opening ... NY. On June 12, Westchester County’s business community ... propelled the first electric car and powered the ... moon landing in an opening celebration showcasing VARTA’s ...
(Date:6/15/2013)... 2013 The topics that will be ... scrum framework, scrum roles, scrum meetings, scrum artifacts, and ... units (8 PDUs) for attending them. , These trainings ... managers, directors. It is also ideal for those who ... outside the software industry or those who want to ...
(Date:6/14/2013)... The OpenClinica Global Conference ... this year with Formedix CEO, Mark Wheeldon presenting as ... attendees a deeper insight into the future developments at ... as Formedix to develop innovative solutions. , The conference ... about OpenClinica, hear real-life case studies and discover more ...
(Date:6/14/2013)... SOUTH EASTON, Mass. , June 14, 2013 /PRNewswire/ ... today announced that it has closed the third and ... Convertible Preferred Stock and Warrants (the "Series J Private ... February 6 and $156,900 on March 28, 2013), the ... its Series J Private Placement, slightly over its goal ...
Breaking Biology Technology:VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 2VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 3VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 4Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 2Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 3Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 2Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 3Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 2Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 3Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 4Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 5
... Graduate Institute,(KGI) in collaboration with City of Hope, ... launch of its new Certificate in Bioscience,Management program ... funding to allow a limited number of City ... scholarships that will cover tuition., "KGI has ...
... ALTO, Calif., Aug. 14 CV Therapeutics,Inc. (Nasdaq: ... from the,European Medicines Agency (EMEA) for the brand name ... announced that the EMEA had granted,marketing authorization for ranolazine ... brand name Latixa., "Securing approval for the Ranexa ...
... Eric P. Loukas, Industry Veteran, Named as CEO ... Co-Founder, Named as President and COO, ALTAMONTE SPRINGS, ... specialty biotechnology company focused on,in-licensing and commercialization of niche ... as Chief Executive Officer,effective August 12, 2008. Current President, ...
Cached Biology Technology:City of Hope Helps KGI Launch New Management Training Program for Scientists 2City of Hope Helps KGI Launch New Management Training Program for Scientists 3CV Therapeutics Receives European Approval for the Brand Name Ranexa(R) 2Milestone Biosciences, LLC Further Strengthens Executive Management Team 2
(Date:6/17/2013)... by fungi, bacteria, and algae, is a common component ... used in the medical field it,s approved by ... fluids and used during surgery as a substance that ... other drugs. , Now Profs. Ehud Gazit and Daniel ... and Biotechnology and the Sagol School of Neuroscience, along ...
(Date:6/17/2013)... will be the topics under discussion during the ... the third consecutive year, this will be a ... experiences among members of Academy, Business, Educators, Entrepreneurs, ... speakers: Elisa Martn Garijo (IBM South Europe), Chris ... Mary O,Donovan (Hovione), among others. E3 Forum - ...
(Date:6/17/2013)... available in French . ... older mice with Alzheimer,s disease can be reversed with treatment. ... Hospital - The Neuro, at McGill University and at Universit ... receptor in the brain of mice with advanced Alzheimer,s disease ... the Journal of Neuroinflammation in May, also suggest ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2'E3 Forum -- Education, Employment & Entrepreneurship on a Global context' 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2
... Gasterosteus aculeatus , is one of the most thoroughly ... particularly useful model for understanding variation in physiology, behavior, ... in the wild. On biological levels from molecular ... with the population level, it has proven far more ...
... a little gooey, but it,s not turning mums, brains into ... University. The study conducted by the Centre for ... fears mothers may have that pregnancy affects their cognitive functions, ... findings have been released as part of Mental Health Week, ...
... ability to respond? Biodiversity in a Warmer World, published ... Science , illustrates that cross-disciplinary research fostered by ... this urgent debate. , As an extremely diverse region ... the most to lose as a result of global ...
Cached Biology News:Fitness in a changing world 2Fitness in a changing world 3Pregnancy not turning minds to mush: Study 2Smithsonian perspective: Biodiversity in a warmer world 2
... form from a hematopoietic stem cells called ... the bone surface and lowering the surrounding ... 4.5. The bone mineral is then solubilized ... function is controlled primarily by Macrophage Colony-Stimulating ...
Values of steady state parameters for enzyme activities are determined....
... Receptor-gamma (PPAR) is a member of ... transcription factors that heterodimerize with retinoic ... in the regulation of glucose and ... class of anti-diabetic agents called thiazolidinediones ...
... includes 1. Scanning of gel(s) 2. ... tryptic in-gel digestion and peptide extraction ... 5. Acquisition of PMF (Peptide Mass ... TOF/TOF) 6. Acquisition of PFF (Peptide ...
Biology Products: